We are live on
!
Find out more
C
Consulta Portfolio holdings
AUM
$2.77B
1-Year Est. Return
3.62%
This Fund
S&P 500
This Quarter
Est. Return
-12.62%
1 Year Est. Return
+3.62%
3 Year Est. Return
+30.69%
5 Year Est. Return
+30.14%
10 Year Est. Return
+206.35%
AUM
$947M
AUM Growth
-$157M
(-14%)
Cap. Flow
+$9.3M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
88.54%
Holding
17
New
6
Increased
2
Reduced
4
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.2M |
| 2 |
HCA Healthcare
HCA
|
+$88.5M |
| 3 |
JAH
JARDEN CORPORATION
JAH
|
+$59.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$58.6M |
| 5 |
DaVita
DVA
|
+$58.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$120M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$96.7M |
| 3 |
NLSN
Nielsen Holdings plc
NLSN
|
+$89.5M |
| 4 |
Allison Transmission
ALSN
|
+$35.8M |
| 5 |
Bausch Health
BHC
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.73% |
| 2 | Technology | 12.87% |
| 3 | Communication Services | 12.07% |
| 4 | Real Estate | 10.9% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sensata Technologies
ST
$6.22B
| $122M | 12.87% |
2,750,000
+500,000
| +22% | +$24.2M |
|
2
Charter Communications
CHTR
$18.2B
| $114M | 12.07% |
650,000
+150,000
| +30% | +$27.4M |
|
3
Howard Hughes
HHH
$4.07B
| $103M | 10.9% |
944,100
| – | – |
|
|
4
Bausch Health
BHC
$2.58B
| $89.2M | 9.42% |
500,000
-150,000
| -23% | -$35M |
|
|
5
Allison Transmission
ALSN
$10.3B
| $86.7M | 9.16% |
3,250,000
-1,250,000
| -28% | -$35.8M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $81.5M | 8.61% |
+300,000
| New | +$92.2M |
|
|
7
HCA Healthcare
HCA
$88.1B
| $77.4M | 8.17% |
+1,000,000
| New | +$88.5M |
|
|
8
Thermo Fisher Scientific
TMO
$227B
| $55M | 5.81% |
+450,000
| New | +$58.6M |
|
|
JAH
9
DELISTED
JARDEN CORPORATION
JAH
| $55M | 5.81% |
+1,125,000
| New | +$59.5M |
|
|
10
DaVita
DVA
$11.3B
| $54.2M | 5.73% |
+750,000
| New | +$58.2M |
|
11
Element Solutions
ESI
$8.82B
| $44.3M | 4.67% |
3,500,000
-1,500,000
| -30% | -$30.9M |
|
12
Berkshire Hathaway Class B
BRK.B
$1.07T
| $33M | 3.48% |
+253,060
| New | +$34.7M |
|
13
American International
AIG
$39.6B
| $31.3M | 3.3% |
550,000
-200,000
| -27% | -$12.2M |
|
14
XPO
XPO
$23.1B
| – | – |
-888,569
| Closed | -$13.9M |
|
|
TFCF
15
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| – | – |
-3,000,000
| Closed | -$96.7M |
|
|
MON
16
DELISTED
Monsanto Co
MON
| – | – |
-1,125,000
| Closed | -$120M |
|
|
NLSN
17
DELISTED
Nielsen Holdings plc
NLSN
| – | – |
-2,000,000
| Closed | -$89.5M |
|
Similar funds
HCM
BGM
SIM
JHP
DJSG
CAAS
CCM
FFA
Consulta's Q3 2015 Portfolio in Review
As of Q3 2015, Consulta held 17 positions worth $947M, down 14% from $1.1B the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Consulta's Q3 2015 filing shows 6 new, 2 increased, 4 reduced and 4 closed positions. Its largest new stake was Allergan plc: 300,000 shares worth $81.5M. The largest sale was Monsanto Co, an estimated $120M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 13% a quarter earlier, followed by Technology and Communication Services.
- Consulta's largest Q3 2015 buy was Allergan plc: 300,000 shares worth $81.5M.
- Consulta added most to Charter Communications in Q3 2015, an estimated $27.4M increase.
- Consulta's biggest Q3 2015 reduction was Allison Transmission, cutting an estimated $35.8M.
- Consulta fully exited Monsanto Co in Q3 2015, selling an estimated $120M.
- Consulta's ten largest holdings make up 89% of its $947M portfolio in Q3 2015.
- Consulta opened 6 new positions and closed 4 in Q3 2015.
- Consulta's portfolio value fell 14% quarter-over-quarter to $947M.
Based on Consulta's 13F filing for Q3 2015, filed 16 Nov 2015.